Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001660410-19-000001
Filing Date
2019-01-04
Accepted
2019-01-04 16:09:28
Documents
1
Effectiveness Date
2019-01-04
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10667
  Complete submission text file 0001660410-19-000001.txt   11748
Mailing Address 99 HAYDEN AVENUE BUILDING D, SUITE 100 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE BUILDING D, SUITE 100 LEXINGTON MA 02421 617-914-8700
Ribon Therapeutics, Inc. (Filer) CIK: 0001660410 (see all company filings)

EIN.: 473651475 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-329723 | Film No.: 19510107